Hint mode is switched on Switch off
For swift navigation between sections

Novartis Capital
LEI 5493002KF87V5RSRQS84

PDF download

Choose all Reset all
Download Cancel
Organization name
Novartis Capital Corporation
Country name
Switzerland
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
2,750 mln USD

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Novartis Capital Corporation is a finance subsidiary indirectly owned 100% by Novartis AG and was incorporated as a corporation under the laws of Delaware on July 23, 2008. It exists for the purpose of issuing debt securities, the proceeds of which will be invested by it in marketable securities or advanced to, or otherwise invested in, subsidiaries or affiliates of Novartis AG.

Awards

News

17/03/2026 Upcoming Issue: Novartis Capital
07/11/2025 New issue: Novartis Capital issued international bonds (US66989HAY45) with the coupon rate of 4.1% in the amount of USD 1750 mln maturing in 2030
15/02/2017 New bond issue: Novartis Capital issued international bonds for USD 1,000.0m maturing in 2027 with a 3.1% coupon.
15/02/2017 New bond issue: Novartis Capital issued international bonds for USD 1,000.0m maturing in 2022 with a 2.4% coupon.
15/02/2017 New bond issue: Novartis Capital issued international bonds for USD 1,000.0m maturing in 2020 with a 1.8% coupon.
All organization news

Documentation

Affiliates

Stocks

Latest issues

Show all

Bond classification

  • Organization does not disclose IFRS/US GAAP financial statements

Public debt by currencies

Show more Hide

Codes

  • LEI
    5493002KF87V5RSRQS84
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001443411
Registration is required to get access.